Activist Investor Echo Lake Capital Launches Takeover Bid for Crashing Aclarion Stock
Echo Lake offers $4/share to buy Aclarion, plus profit rights; says company is undervalued and wants reply by June 4, 2026.
/ 495 items
#XY Event-Driven Stocks↓
Teladoc Health Partners with Walmart to Offer Virtual Doctor Visits
Teladoc Health and Walmart launch cheap virtual care for urgent, skin, and nutrition needs via Walmart app.
TD Cowen & Evercore ISI Praise “Compelling” EDIT-401 Data as Editas Eyes 2026 Human Trials
Editas’ gene therapy EDIT-401 cut bad cholesterol ~90% in animals; analysts bullish; human trials expected in 2026.
Biohaven Shares Surge as New Drugs Deliver Breakthrough Results in Graves’ Disease and IgA Nephropathy
Biohaven shares rose after strong early results from 2 drugs that quickly lower harmful antibodies in autoimmune diseases.
Japan Grants Orphan Drug Designation to Vanda’s Imsidolimab for Rare Skin Disease GPP
Vanda’s drug imsidolimab receives orphan drug status in Japan for the rare skin disease GPP, speeding up approval.
FDA Review Back on Track – Corcept Resubmits Relacorilant for Cushing’s Treatment
Corcept will resubmit its NDA for relacorilant to treat Cushing’s syndrome after positive FDA feedback.